William H. Chang - Jun 23, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director, 10%+ Owner
Signature: /s/ William Chang
Stock symbol: ENSC
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/27/2022, 05:47 PM
Previous filing: Feb 4, 2022
Next filing: May 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENSC	Common Stock						353K	Jun 23, 2022	Direct
holding	ENSC	Common Stock						2.24M	Jun 23, 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Stock Option	Award		+15K	+75%		35K	Jun 23, 2022	Common Stock	15K	$0.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.